Viva Biotech Holdings (1873.HK)

HKD 1.44

(6.67%)

Net Income Summary of Viva Biotech Holdings

  • Viva Biotech Holdings's latest annual net income in 2023 was -116.11 Million CNY , up 78.03% from previous year.
  • Viva Biotech Holdings's latest quarterly net income in 2024 Q2 was 116.8 Million CNY , down 0.0% from previous quarter.
  • Viva Biotech Holdings reported an annual net income of -528.47 Million CNY in 2022, down -283.79% from previous year.
  • Viva Biotech Holdings reported an annual net income of 287.54 Million CNY in 2021, up 174.32% from previous year.
  • Viva Biotech Holdings reported a quarterly net income of -116.11 Million CNY for 2023 FY, up 78.03% from previous quarter.
  • Viva Biotech Holdings reported a quarterly net income of 1.01 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Net Income Chart of Viva Biotech Holdings (2023 - 2016)

Historical Annual Net Income of Viva Biotech Holdings (2023 - 2016)

Year Net Income Net Income Growth
2023 -116.11 Million CNY 78.03%
2022 -528.47 Million CNY -283.79%
2021 287.54 Million CNY 174.32%
2020 -386.88 Million CNY -245.51%
2019 265.87 Million CNY 193.62%
2018 90.55 Million CNY 18.74%
2017 76.26 Million CNY 211.61%
2016 24.47 Million CNY 0.0%

Peer Net Income Comparison of Viva Biotech Holdings

Name Net Income Net Income Difference
Uni-Bio Science Group Limited 70.87 Million HKD 263.826%
CK Life Sciences Int'l., (Holdings) Inc. 17.25 Million HKD 773.119%